Peter J Lenting (Peter Lenting)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Venues

Blood

Journal of thrombosis and haemostasis : JTH

Nature communications

CPT: pharmacometrics & systems pharmacology

INSERM

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM Mar 01 2009

France

Director of Research (DR1) :: Unit 1176

Crucell Holland BV Aug 01 2007 - Feb 28 2009

Netherlands

Director :: Protein Discovery

University Medical Center Utrecht Jun 01 2000 - Sep 01 2007

Netherlands

Associate professor :: Haematology

Sanquin Research/ CLB May 01 1989 - May 31 2000

Netherlands

PhD-student/Research fellow :: Plasma Proteins

Publications

Romain Muller, Raphaël Cauchois, Marie Lagarde, Sandrine Roffino, Cécile Genovesio, Samantha Fernandez, Guillaume Hache, Benjamin Guillet, Yéter Kara, Marion Marlinge, Peter J Lenting, Pascale Poullin, Françoise Dignat-George, Edwige Tellier, Gilles Kaplanski
Reduction of mortality, cardiac damage, and cerebral damage by IL-1 inhibition in a murine model of TTP. Blood 143 (26) (2024)
Romain Muller, Raphaël Cauchois, Marie Lagarde, Sandrine Roffino, Cécile Genovesio, Samantha Fernandez, Guillaume Hache, Benjamin Guillet, Yéter Kara, Marion Marlinge, Peter J Lenting, Pascale Poullin, Françoise Dignat-George, Edwige Tellier, Gilles Kaplanski
Reduction of mortality, cardiac damage, and cerebral damage by IL-1 inhibition in a murine model of TTP. Blood 143 (26) (2024)
Hinde El Otmani, Rowan Frunt, Simone Smits, Arjan D Barendrecht, Steven de Maat, Rob Fijnheer, Peter J Lenting, Claudia Tersteeg
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis. Blood 143 (20) (2024)
Romain Muller, Raphaël Cauchois, Marie Lagarde, Sandrine Roffino, Cecile Genovesio, Samantha Fernandez, Guillaume Hache, Benjamin Guillet, Yeter Kara, Marion Marlinge, Peter J Lenting, Pascale Poullin, Françoise Dignat-George, Edwige Tellier, Gilles Kaplanski
Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP. Blood (2024)
Sebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, Frédéric Adam, Caterina Casari, Laurence Panicot-Dubois, Lydie Crescence, Christophe Dubois, Cecile V Denis, Peter J Lenting, Olivier D Christophe
Fitusiran reduces bleeding in factor X-deficient mice. Blood 144 (2) (2024)
Hinde El Otmani, Rowan Frunt, Simone Smits, Arjan D Barendrecht, Steven de Maat, Rob Fijnheer, Peter J Lenting, Claudia Tersteeg
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis. Blood 143 (20) (2024)
Sebastien Verhenne, Geneviève McCluskey, Hortense Maynadié, Frédéric Adam, Caterina Casari, Laurence Panicot-Dubois, Lydie Crescence, Christophe Dubois, Cecile V Denis, Peter J Lenting, Olivier D Christophe
Fitusiran reduces bleeding in factor X-deficient mice. Blood 144 (2) (2024)
Hinde El Otmani, Rowan Frunt, Simone Smits, Arjan D Barendrecht, Steven de Maat, Rob Fijnheer, Peter J Lenting, Claudia Tersteeg
Plasmin-cleaved Von Willebrand Factor as a biomarker for microvascular thrombosis. Blood (2024)
Hinde El Otmani, Rowan Frunt, Simone Smits, Arjan D Barendrecht, Steven de Maat, Rob Fijnheer, Peter J Lenting, Claudia Tersteeg
Plasmin-cleaved Von Willebrand Factor as a biomarker for microvascular thrombosis. Blood (2024)
Peter J Lenting, Cecile V Denis, Olivier D Christophe
Von Willebrand factor: how unique structural adaptations support and coordinate its complex function. Blood (2024)
Hinde El Otmani, Rowan Frunt, Simone Smits, Arjan D Barendrecht, Steven de Maat, Rob Fijnheer, Peter J Lenting, Claudia Tersteeg
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis. Blood 143 (20) (2024)
Sebastien Verhenne, Genevieve McCluskey, Hortense Maynadié, Frédéric Adam, Caterina Casari, Laurence Panicot-Dubois, Lydie Crescence, Christophe Dubois, Cecile V Denis, Peter J Lenting, Olivier D Christophe
Fitusiran reduces bleeding in Factor X-deficient mice. Blood (2024)
Michael E Cloesmeijer, Erik Sjögren, Sjoerd F Koopman, Peter J Lenting, Marjon H Cnossen, Ron A A Mathot, null null
PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space. CPT: pharmacometrics & systems pharmacology (2024)
Stéphanie Roullet, Norman F Luc, Julie Rayes, Jean Solarz, Dante Disharoon, Andrew J Ditto, Emily Gahagan, Christa Pawlowski, Thibaud Sefiane, Frédéric Adam, Caterina Casari, Olivier D Christophe, Michael A Bruckman, Peter J Lenting, Anirban Sen Gupta, Cecile V Denis
Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models. Blood (2023)
Antoine Rauch, Annabelle Dupont, Mickael Rosa, Maximilien Desvages, Christina Le Tanno, Johan Abdoul, Mélusine Didelot, Alexandre Ung, Richard Ruez, Emmanuelle Jeanpierre, Mélanie Daniel, Delphine Corseaux, Hugues Spillemaeker, Julien Labreuche, Bénédicte Pradines, Natacha Rousse, Peter J Lenting, Mouhamed D Moussa, André Vincentelli, Jean Claude Bordet, Bart Staels, Flavien Vincent, Cecile V Denis, Eric Van Belle, Caterina Casari, Sophie Susen
Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia. Circulation research 133 (10) (2023)
Claire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard, Gaelle Claire Le Goff, Solen Lenoir, Sandra Damodaran, Marie Clavel, Stéphanie Roullet, Veronique Regnault, Antoine Rauch, Flavien Vincent, Emmanuelle Jeanpierre, Annabelle Dupont, Catherine Ternisien, Thibault Donnet, Olivier D Christophe, Eric Van Belle, Cecile V Denis, Caterina Casari, Sophie Susen, Peter J Lenting
A nanobody against the von Willebrand factor A3-domain detects ADAMTS13-induced proteolysis in congenital & acquired VWD. Blood (2022)
Cecile V Denis, Peter J Lenting, Denis Wahl
TaSER: Combining forces to stop the clot. Journal of thrombosis and haemostasis : JTH 20 (2) (2022)
Peter J Lenting, Claire Kizlik-Manson, Caterina Casari
Towards novel treatment options in von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Claire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard, Gaelle Claire Le Goff, Solen Lenoir, Sandra Damodaran, Marie Clavel, Stéphanie Roullet, Veronique Regnault, Antoine Rauch, Flavien Vincent, Emmanuelle Jeanpierre, Annabelle Dupont, Catherine Ternisien, Thibault Donnet, Olivier D Christophe, Eric Van Belle, Cecile V Denis, Caterina Casari, Sophie Susen, Peter J Lenting
A nanobody against the von Willebrand factor A3-domain detects ADAMTS13-induced proteolysis in congenital & acquired VWD. Blood (2022)
Sophie Susen, Antoine Rauch, Peter J Lenting
Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19: Response from Original Authors Susen, et al. Journal of thrombosis and haemostasis : JTH 18 (12) (2021)
Julie Lachaux, Gilgueng Hwang, Nassim Arouche, Sina Naserian, Abdelmounaim Harouri, Valeria Lotito, Caterina Casari, Thevy Lok, Jean Baptiste Menager, Justin Issard, Julien Guihaire, Cecile V Denis, Peter J Lenting, Abdul I Barakat, Georges Uzan, Ida Chiara Guerrera, Anne-Marie Haghiri-Gosnet
A compact integrated microfluidic oxygenator with high gas exchange efficiency and compatibility for long-lasting endothelialization. Lab on a chip 21 (24) (2021)
Steven de Maat, Chantal C Clark, Arjan D Barendrecht, Simone Smits, Nadine D van Kleef, Hinde El Otmani, Manon Waning, Marc Vincent Adriaan van Moorsel, Michael Szardenings, Nicolas Delaroque, Kristof Vercruysse, Rolf T Urbanus, Silvie Sebastian, Peter J Lenting, Christoph Eugen Hagemeyer, Thomas Renne, Karen Vanhoorelbeke, Claudia Tersteeg, Coen Maas
Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis. Blood (2021)
Charlotte Kawecki, Karen Aymonnier, Stephen Ferrière, Laurence Venisse, Véronique Arocas, Yacine Boulaftali, Olivier D Christophe, Peter J Lenting, Marie-Christine Bouton, Cecile V Denis
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generation. Journal of thrombosis and haemostasis : JTH 18 (9) (2021)
Wariya Sanrattana, Thibaud Sefiane, Simone Smits, Nadine D van Kleef, Marcel H Fens, Peter J Lenting, Coen Maas, Steven de Maat
A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs. Proceedings of the National Academy of Sciences of the United States of America 118 (45) (2021)
Matteo Campioni, Paulette Legendre, Cécile Loubiere, Barbara Lunghi, Mirko Pinotti, Olivier D Christophe, Peter J Lenting, Cecile V Denis, Francesco Bernardi, Caterina Casari
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A. Journal of thrombosis and haemostasis : JTH 19 (1) (2020)
Ivan Peyron, Claire Kizlik-Masson, Marie-Daniéla Dubois, Sénadé Atsou, Stephen Ferrière, Cecile V Denis, Peter J Lenting, Caterina Casari, Olivier D Christophe
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications. Research and practice in thrombosis and haemostasis 4 (7) (2020)
Antoine Rauch, Julien Labreuche, Fanny Lassalle, Julien Goutay, Morgan Caplan, Leslie Charbonnier, Aurelien Rohn, Emmanuelle Jeanpierre, Annabelle Dupont, Alain Duhamel, Karine Faure, Marc Lambert, Eric Kipnis, Delphine Garrigue, Peter J Lenting, Julien Poissy, Sophie Susen
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. Journal of thrombosis and haemostasis : JTH 18 (11) (2020)
Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J Lenting, Jean-Paul Concordet, Magali Toueille, Annarita Miccio, Mario Amendola
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature communications 11 (1) (2020)
Elena Barbon, Gabriel Ayme, Amel Mohamadi, Jean-François Ottavi, Charlotte Kawecki, Caterina Casari, Sebastien Verhenne, Solenne Marmier, Laetitia van Wittenberghe, Severine Charles, Fanny Collaud, Cecile V Denis, Olivier D Christophe, Federico Mingozzi, Peter J Lenting
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors. EMBO molecular medicine 12 (4) (2020)
Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J Lenting, Jean-Paul Concordet, Magali Toueille, Annarita Miccio, Mario Amendola
Author Correction: Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature communications 11 (1) (2020)
Cecile V Denis, Peter J Lenting
VWF clearance: it's glycomplicated. Blood 131 (8) (2019)
Vincent Muczynski, Caterina Casari, François Moreau, Gabriel Aymé, Charlotte Kawecki, Paulette Legendre, Valerie Proulle, Olivier D Christophe, Cecile V Denis, Peter J Lenting
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation. Blood 132 (11) (2018)

Peter J Lenting.css-eqlu8i{font-size:small;padding-left:4px;} (Peter Lenting)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter J Lenting (Peter Lenting)